β2-Adrenergic receptor stimulation-induced immunosuppressive effects possibly through down-regulation of co-stimulatory molecules, ICAM-1, CD40 and CD14 on monocytes

Journal of International Medical Research

Volumn 32, Issue 5, 2004, Pages 465-483

  Kuroki, K ^a,b   Takahashi, H K ^a   Iwagaki, H ^a   Murakami, T ^c   Kuinose, M ^c   Hamanaka, S ^d   Minami, K ^d   Nishibori, M ^a   Tanaka, N ^a   Tanemoto, K ^d  

^a OKAYAMA UNIVERSITY   (Japan)

^b NATIONAL HOSPITAL ORGANIZATION FUKUYAMA MEDICAL CENTER   (Japan)

^c IWAKUNI NATIONAL HOSPITAL   (Japan)

^d KAWASAKI MEDICAL SCHOOL   (Japan)

Author keywords

Adrenergic receptor; CD40; Intercellular adhesion molecule 1 (ICAM 1); Monocytes; Tumour necrosis factor (TNF)

Indexed keywords

ADRENALIN; ATENOLOL; B7 ANTIGEN; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BUTOXAMINE; CATECHOLAMINE; CD14 ANTIGEN; CD40 ANTIGEN; CD40 LIGAND; CD86 ANTIGEN; INTERCELLULAR ADHESION MOLECULE 1; ISOPRENALINE; LIPOPOLYSACCHARIDE; NORADRENALIN; PRAZOSIN; SALBUTAMOL; TERBUTALINE; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA; YOHIMBINE; BETA 2 ADRENERGIC RECEPTOR; CELL SURFACE RECEPTOR; MEMBRANE PROTEIN; TOLL LIKE RECEPTOR;

ARTICLE; BETA ADRENERGIC STIMULATION; CONTROLLED STUDY; DOWN REGULATION; DRUG ANTAGONISM; DRUG EFFECT; ENZYME INHIBITION; HELPER CELL; HUMAN; HUMAN CELL; IMMUNOMODULATION; IMMUNOSUPPRESSIVE TREATMENT; INFECTION; LYMPHOCYTE PROLIFERATION; MONOCYTE; MONONUCLEAR CELL; NORMAL HUMAN; PROTEIN EXPRESSION; STRESS; CELL PROLIFERATION; DOSE RESPONSE; DRUG POTENTIATION; IMMUNOLOGICAL TOLERANCE; IMMUNOLOGY; METABOLISM; PHYSIOLOGY; T LYMPHOCYTE;

ALBUTEROL; ANTIGENS, CD14; ANTIGENS, CD40; BUTOXAMINE; CELL PROLIFERATION; DOSE-RESPONSE RELATIONSHIP, DRUG; DOWN-REGULATION; HUMANS; IMMUNE TOLERANCE; INTERCELLULAR ADHESION MOLECULE-1; LIPOPOLYSACCHARIDES; MEMBRANE GLYCOPROTEINS; MONOCYTES; RECEPTORS, ADRENERGIC, BETA-2; RECEPTORS, CELL SURFACE; T-LYMPHOCYTES; TERBUTALINE; TOLL-LIKE RECEPTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 4544316853     PISSN: 03000605     EISSN: None     Source Type: Journal    
DOI: 10.1177/147323000403200503     Document Type: Article

References (37)

1. Greenfield EA, Nguyen KA, Kuchroo VK: CD28/B7 costimulation: a review. Crit Rev Immunol 1998; 18: 389-418.
2. Dustin ML, Springer TA: T-cell receptor cross-linking transiently stimulates adhesiveness through LFA-1. Nature 1989; 341: 619-624.
3. Sedwick CE, Morgan MM, Jusino L, Cannon JL, Miller J, Burkhardt JK: TCR, LFA-1 and CD28 play unique and complementary roles in signalling T-cell cytoskeletal reorganization. J Immunol 1999; 162: 1367-1375.
4. Tan P, Anasetti C, Hansen JA, Melrose J, Brunvand M, Bradshaw J, et al: Induction of alloantigen-specific hyporesponsiveness in human T lymphocytes by blocking interaction of CD28 with its natural ligand B7/BB1. J Exp Med 1993; 177: 165-173.
5. Luft T, Jefford M, Luetjens P, Hochrein H, Masterman KA, Maliszewski C, et al: IL-1 beta enhances CD40 ligand-mediated cytokine secretion by human dendritic cells (DC): a mechanism for T-cell-independent DC activation. J Immunol 2002; 168: 713-722.
6. Fabrega E, Castro B, Crespo J, de la Pena J, Gomez-Fleitas M, Garcia-Unzueta MT, et al: Different time course of circulating adhesion molecules and hyaluran during hepatic allograft rejection. Transplantation 2000; 69: 569-573.
7. Park SY, Kim HW, Moon KC, Hong HK, Lee HS: mRNA expression of intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 in acute renal allograft rejection. Transplantation 2000; 69: 2554-2560.
8. Zhang XP, Kelemen SE, Eisen HJ: Quantitative assessment of cell adhesion molecule gene expression in endomyocardial biopsy specimens from cardiac transplant recipients using competitive polymerase chain reaction. Transplantation 2000; 70: 505-513.
9. Zhu SN, Yamada J, Streilein JW, Dana MR: ICAM-1 deficiency suppresses host allosensitization and rejection of MHC-disparate corneal transplants. Transplantation 2000; 69: 1008-1013.
10. Sayegh MH, Turka LA: The role of T-cell costimulatory activation pathways in transplant rejection. N Engl J Med 1998; 338: 1813-1821.
11. Shimizu K, Schonbeck U, Mach F, Libby P, Mitchell RN: Host CD40 ligand deficiency induces long-term allograft survival and donor-specific tolerance in mouse cardiac transplantation but does not prevent graft arteriosclerosis. J Immunol 2000; 165: 3506-3518.
12. Raetz CR, Ulevitch RJ, Wright SD, Sibley CH, Ding A, Nathan CF: Gram-negative endotoxin: an extraordinary lipid with profound effects on eukaryotic signal transduction. FASEB J 1991; 5: 2652-2660.
13. Ulevitch RJ, Tobias PS: Receptor-dependent mechanisms of cell stimulation by bacterial endotoxin. Annu Rev Immunol 1995; 13: 437-457.
14. Cerami A, Beutler B: The role of cachectin/TNF in endotoxic shock and cachexia. Immunol Today 1988; 9: 28-31.
15. Wright SD, Ramos RA, Tobias PS, Ulevitch RJ, Mathison JC: CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science 1990; 249: 1431-1433.
16. Aderem A, Ulevitch RJ: Toll-like receptors in the induction of the innate immune response. Nature 2000; 406: 782-787.
17. Yang RB, Mark MR, Gray A, Huang A, Xie MH, Zhang M, et al: Toll-like receptor-2 mediates lipopolysaccharide-induced cellular signalling. Nature 1998; 395: 284-288.
18. Poltorak A, He X, Smirnova I, Liu MY, Huffel CV, Du X, et al: Defective LPS signalling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 1998; 282: 2085-2088.
19. Schumann RR, Pfeil D, Lamping N, Kirschning C, Scherzinger G, Schlag P, et al: Lipopolysaccharide induces the rapid tyrosine phosphorylation of the mitogen-activated protein-kinase erk-1 and p38 in cultured human vascular endothelial cells requiring the presence of soluble CD14. Blood 1996; 87: 2805-2814.
20. Felten DL, Felten SY, Bellinger DL, Carlson SL, Ackerman KD, Madden KS, et al: Noradrenergic sympathetic neural interactions with the immune system: structure and function. Immuno Rev 1987; 100: 225-260.
21. Elenkov IJ, Wilder RL, Chrousos GP, Vizi ES: The sympathetic nerve - an integrative interface between two supersystems: the brain and the immune system. Pharmacol Rev 2000; 52: 595-638.
22. Knudsen JH, Kjaersgaard E, Christensen NJ: Individual lymphocyte subset composition determines cAMP response to isoproterenol in mononuclear cell preparations from peripheral blood. Scand J Clin Lab Invest 1995; 55: 9-14.
23. Elenkov IJ, Chrousos GP, Wilder RL: Neuroendocrine regulation of IL-12 and TNF-alpha/IL-10 balance. Clinical implications. Ann N Y Acad Sci 2000; 917: 94-105.
24. Elenkov IJ, Papanicolaou DA, Wilder RL, Chrousos GP: Modulatory effects of glucocorticoids and catecholamines on human interleukin-12 and interleukin-10 production. Proc Assoc Am Physicians 1996; 108: 374-381.
25. Cohen S, Tyrrell AJ, Smith AP: Psychological stress and susceptibility to the common cold. N Engl J Med 1991; 325: 606-612.
26. Cohen S, Williamson GM: Stress and infectious disease in humans. Psychol Bull 1991; 109: 5-24.
27. Felten DL, Felten SY, Carlson LS, Olschowka JA, Livnat S: Noradrenergic and peptidergic innervation of lymphoid tissue. J Immunol 1985; 135 (Suppl 2): 755S-765S.
28. Shimizu N, Hori T, Nakane H: An interleukin-1b-induced noradrenaline release in the spleen is mediated by brain corticotrophin-releasing factor: an in vivo microdialysis study in conscious rats. Brain Behav Immun 1994; 8: 14-23.
29. Kammer GM: The adenylate cyclase-cAMP-protein kinase A pathway and regulation of the immune response. Immunol Today 1988; 9: 222-229.
30. van Tits LJ, Michel MC, Grosse-Wilde H, Happel M, Eigler FW, Soliman A, et al: Catecholamines increase lymphocyte beta 2-adrenergic receptors via a beta 2-adrenergic, spleen-dependent process. Am J Physiol 1990; 258: E191-E202.
31. Ottaway CA, Husband AJ: Central nervous system influences on lymphocyte migration. Brain Behav Immun 1992; 6: 97-116.
32. Ottaway CA, Husband AJ: The influence of neuroendocrine pathways on lymphocyte migration. Immunol Today 1994; 15: 511-517.
33. Sanders VM, Baker RA, Ramer-Quinn DS, Kasprowicz DJ, Fuchs BA, Street NE: Differential expression of the beta 2-adrenergic receptor by Th1 and Th2 clones: implications for cytokine production and B cell help. J Immunol 1997; 158: 4200-4210.
34. Vizi ES, Elenkov IJ: Nonsynaptic noradrenaline release in neuro-immune responses. Acta Biol Hung 2002; 53: 229-244.
35. Townley RG, Horiba M: Airway hyperresponsiveness: a story of mice and men and cytokines. Clin Rev Allergy Immunol 2003; 24: 85-110.
36. Agarwal SK, Marshall GD: Beta-adrenergic modulation of human type-1/type-2 cytokine balance. J Allergy Clin Immunol 2000; 105: 91-98.
37. Uotila P: The role of cyclic AMP and oxygen intermediates in the inhibition of cellular immunity in cancer. Cancer Immunol Immunother 1996; 43: 1-9.